Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Isabelle Goddard

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
Endocrinology|February 17, 2007
Leptin-mediated decrease of cyclin A2 and increase of cyclin D1 expression: relevance for the control of prepubertal rat Leydig cell division and differentiationJoanna Fombonne, Céline Charrier, Isabelle Goddard, et al.
Genesis (New York, N.Y. : 2000)|April 9, 2008
Use of ERT2-iCre-ERT2 for conditional transgenesisNicolas Jullien, Isabelle Goddard, Samia Selmi-Ruby, et al.
Plos One|December 27, 2007
Conditional transgenesis using Dimerizable Cre (DiCre)Nicolas Jullien, Isabelle Goddard, Samia Selmi-Ruby, et al.
Molecular and Cellular Endocrinology|August 29, 2003
Alteration of lactate production and transport in the adult rat testis exposed in utero to flutamideIsabelle Goddard, Anne Florin, Claire Mauduit, et al.
Human Gene Therapy|September 28, 2011
Inactivation of transcription factor pit-1 to target tumoral somatolactotroph cellsCatherine Roche, Ramahefarizo Rasolonjanahary, Sylvie Thirion, et al.
Molecular Cancer Therapeutics|October 21, 2017
Combinatorial Treatment with mTOR Inhibitors and Streptozotocin Leads to Synergistic <i>In Vitro</i> and <i>In Vivo</i> Antitumor Effects in Insulinoma CellsJulien Bollard, Céline Patte, Patrick Massoma, et al.
The Journal of Pathology|July 2, 2019
Neuropilin-2 contributes to tumor progression in preclinical models of small intestinal neuroendocrine tumorsJulien Bollard, Céline Patte, Kristina Radkova, et al.
Oncogene|December 16, 2020
Men1 disruption in Nkx3.1-deficient mice results in AR<sup>low</sup>/CD44<sup>+</sup> microinvasive carcinoma development with the dysregulated AR pathwayRomain Teinturier, Yakun Luo, Myriam Decaussin-Petrucci, et al.
Cancer Research|February 16, 2020
Blocking SHH/Patched Interaction Triggers Tumor Growth Inhibition through Patched-Induced ApoptosisPierre-Antoine Bissey, Pauline Mathot, Catherine Guix, et al.
Cellular and Molecular Gastroenterology and Hepatology|July 29, 2017
Acinar-to-Ductal Metaplasia Induced by Transforming Growth Factor Beta Facilitates KRAS<sup>G12D</sup>-driven Pancreatic TumorigenesisNicolas Chuvin, David F Vincent, Roxane M Pommier, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Endocrinology|February 17, 2007
Leptin-mediated decrease of cyclin A2 and increase of cyclin D1 expression: relevance for the control of prepubertal rat Leydig cell division and differentiationJoanna Fombonne, Céline Charrier, Isabelle Goddard, et al.
Genesis (New York, N.Y. : 2000)|April 9, 2008
Use of ERT2-iCre-ERT2 for conditional transgenesisNicolas Jullien, Isabelle Goddard, Samia Selmi-Ruby, et al.
Plos One|December 27, 2007
Conditional transgenesis using Dimerizable Cre (DiCre)Nicolas Jullien, Isabelle Goddard, Samia Selmi-Ruby, et al.
Molecular and Cellular Endocrinology|August 29, 2003
Alteration of lactate production and transport in the adult rat testis exposed in utero to flutamideIsabelle Goddard, Anne Florin, Claire Mauduit, et al.
Human Gene Therapy|September 28, 2011
Inactivation of transcription factor pit-1 to target tumoral somatolactotroph cellsCatherine Roche, Ramahefarizo Rasolonjanahary, Sylvie Thirion, et al.
Molecular Cancer Therapeutics|October 21, 2017
Combinatorial Treatment with mTOR Inhibitors and Streptozotocin Leads to Synergistic <i>In Vitro</i> and <i>In Vivo</i> Antitumor Effects in Insulinoma CellsJulien Bollard, Céline Patte, Patrick Massoma, et al.
The Journal of Pathology|July 2, 2019
Neuropilin-2 contributes to tumor progression in preclinical models of small intestinal neuroendocrine tumorsJulien Bollard, Céline Patte, Kristina Radkova, et al.
Oncogene|December 16, 2020
Men1 disruption in Nkx3.1-deficient mice results in AR<sup>low</sup>/CD44<sup>+</sup> microinvasive carcinoma development with the dysregulated AR pathwayRomain Teinturier, Yakun Luo, Myriam Decaussin-Petrucci, et al.
Cancer Research|February 16, 2020
Blocking SHH/Patched Interaction Triggers Tumor Growth Inhibition through Patched-Induced ApoptosisPierre-Antoine Bissey, Pauline Mathot, Catherine Guix, et al.
Cellular and Molecular Gastroenterology and Hepatology|July 29, 2017
Acinar-to-Ductal Metaplasia Induced by Transforming Growth Factor Beta Facilitates KRAS<sup>G12D</sup>-driven Pancreatic TumorigenesisNicolas Chuvin, David F Vincent, Roxane M Pommier, et al.
Pageof 2